腹腔镜胃癌根治术后NSAIDs(IV-PCA)使用对短期结局的影响
该回顾性单中心研究纳入2150例接受腹腔镜胃癌根治术的患者,按术后是否经IV-PCA使用NSAIDs分为非NSAIDs组(n=1215)和NSAIDs组(n=935)。结果显示两组总体并发症率无显著差异(22.7% vs 20.7%,p=0.280),但NSAIDs组吻合口漏、十二指肠残端漏、腹腔出血和腹腔脓肿发生率更高,多因素分析显示NSAIDs使用是早期术后并发症的独立危险因素(1.303 [1.042-1.629],p=0.020)。
要点
- 腹腔镜胃癌术后IV-PCA使用NSAIDs与吻合口漏、十二指肠残端漏、腹腔出血及腹腔脓肿风险升高相关。
- 围术期使用NSAIDs需谨慎,尤其需关注吻合口及腹腔感染相关并发症。
核心结论
- 腹腔镜胃癌根治术后经IV-PCA使用NSAIDs与吻合口漏、十二指肠残端漏、腹腔出血和腹腔脓肿相关,围术期使用NSAIDs应谨慎。
研究设计与样本
- 回顾性单中心研究,纳入2150例接受腹腔镜胃癌根治术的患者,按术后是否使用NSAIDs分为非NSAIDs组(n=1215)和NSAIDs组(n=935)。
主要发现
- 总体并发症率两组无显著差异(22.7% vs 20.7%,p=0.280)。
- NSAIDs组吻合口漏发生率高于非NSAIDs组(2.4% vs 0.7%,p=0.002)。
- NSAIDs组十二指肠残端漏发生率高于非NSAIDs组(1.8% vs 0.6%,p=0.007)。
- NSAIDs组腹腔出血发生率高于非NSAIDs组(2.1% vs 0.7%,p=0.005),腹腔脓肿发生率亦更高(1.5% vs 0.4%,p=0.008)。
- 非NSAIDs组术后肠梗阻发生率更高(3.0% vs 1.4%,p=0.015)。
临床怎么用
- 腹腔镜胃癌根治术后使用IV-PCA时应谨慎选择NSAIDs,尤其对存在吻合口漏或出血风险的患者。
- 术后若使用NSAIDs,需加强监测吻合口漏、十二指肠残端漏、腹腔出血及腹腔脓肿等并发症。
局限性
- 本研究为回顾性单中心研究,可能存在选择偏倚和混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Further data are necessary to evaluate the risk of complications associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs) postoperatively. This study aimed to determine the correlation between the use of NSAIDs in intravenous patient-controlled analgesia (IV-PCA) and postoperative complications after laparoscopic gastrectomy in patients with gastric cancer. METHODS: This retrospective, single-center study was conducted. The study population comprised 2150 patients who underwent laparoscopic gastrectomy for gastric cancer treatment. They were divided into two groups: non-NSAIDs (n = 1215) and NSAIDs (n = 935) according to their use of the drugs. Clinicopathologic characteristics, operative details, postoperative complications within 30 days, risk factors for complications, and survival were analyzed. RESULTS: Of the 2150 patients, 935 (43.49%) used NSAIDs. The overall complication rate showed no significant difference between the NSAIDs and non-NSAIDs groups (22.7% vs. 20.7%, p = 0.280), while the rates of anastomotic leakage and duodenal leakage were higher in the NSAID group (2.4% vs. 0.7%, p = 0.002 and 1.8% vs. 0.6%, p = 0.007, respectively). The rates of intra-abdominal bleeding and intra-abdominal abscess were significantly higher in the NSAID group (2.1% vs. 0.7%, p = 0.005 and 1.5% vs. 0.4%, p = 0.008, respectively). However, postoperative ileus occurred more frequently in the non-NSAID group (3.0% vs. 1.4%, p = 0.015). On multivariate analysis, NSAID use was an independent risk factor for early postoperative complications (1.303 [1.042-1.629], p = 0.020). Meanwhile, the NSAID group showed no differences in overall survival at each pathological stage. CONCLUSION: Postoperative NSAID use by IV-PCA is associated with anastomotic leakage, duodenal stump leakage, intra-abdominal bleeding, and intra-abdominal abscess in patients who underwent laparoscopic gastrectomy for gastric cancer. Caution is advised when NSAIDs are used peri-operatively.
引用
- Kim SJ, Jeon CH, Lee HH, et al. Impact of postoperative NSAIDs (IV-PCA) use on short-term outcomes after laparoscopic gastrectomy for the patients of gastric cancer. Surg Endosc. 2022. PMID: 36131159. doi:10.1007/s00464-022-09600-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。